ArticleThe Journal of dermatology2026

IL-17 Signaling Inhibitors in Localized Scleroderma: A Single-Center Case Series of Nine Patients.

Takuya Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.